By Counterforce Health Team in Palynziq (pegvaliase-pqpz) —

How to Get Palynziq (pegvaliase-pqpz) Covered by Blue Cross Blue Shield in Virginia: Complete Guide with ICD-10, HCPCS Codes, and Appeal Forms

Answer Box: Getting Palynziq Covered in Virginia

Blue Cross Blue Shield Virginia (Anthem) covers Palynziq for adults with PKU when blood phenylalanine levels remain ≥600 µmol/L despite dietary management. Prior authorization is required with strict criteria: age 18+, failed dietary therapy (±sapropterin), specialist involvement, and REMS enrollment.

Fastest path to approval:

  1. Ensure proper ICD-10 coding (E70.0 for classical PKU, E70.1 for other hyperphenylalaninemias)
  2. Submit complete PA with documented step therapy failures
  3. Include REMS enrollment proof for prescriber and patient

First step today: Contact Anthem provider services to verify current PA requirements and obtain Form 216-A for potential appeals.

Table of Contents

  1. Coding Basics: Medical vs. Pharmacy Benefit
  2. ICD-10 Mapping for PKU
  3. Product Coding: HCPCS, NDC, and Units
  4. Clean Request Anatomy
  5. Frequent Pitfalls
  6. Verification Steps
  7. Pre-Submission Audit Checklist
  8. Appeals Process in Virginia
  9. Common Denial Reasons & Solutions
  10. FAQ

Coding Basics: Medical vs. Pharmacy Benefit

Palynziq coverage depends heavily on whether your Blue Cross Blue Shield Virginia plan processes it under the medical benefit or pharmacy benefit—and the coding requirements differ significantly.

Medical Benefit Path

Most Virginia BCBS plans currently process Palynziq as a medical benefit, requiring:

  • HCPCS Code: J3590 (Unclassified biologics)
  • NDC submission: Required on medical claims (CMS-1500/UB-04)
  • Prior authorization: Through medical management
  • Site of care: Often requires specialty pharmacy or clinic administration initially

Pharmacy Benefit Path

Some plans allow pharmacy benefit coverage with:

  • NDC-based billing: Direct pharmacy claims (NCPDP D.0)
  • Specialty pharmacy restriction: Limited distribution network
  • Different PA process: May use pharmacy-specific forms
Tip: Always verify benefit category before starting therapy. Contact Anthem member services at the number on your insurance card to confirm whether Palynziq falls under medical or pharmacy benefits for your specific plan.

ICD-10 Mapping for PKU

Accurate diagnosis coding is critical for Palynziq approval. Virginia BCBS requires specific PKU documentation using these ICD-10 codes:

Primary Codes

ICD-10 Code Description When to Use
E70.0 Classical phenylketonuria Confirmed PAH deficiency, typical PKU presentation
E70.1 Other hyperphenylalaninemias Elevated phenylalanine, non-classic PKU variants

Documentation Requirements

Your medical records must include:

  • Confirmed PKU diagnosis with genetic or biochemical evidence
  • Current phenylalanine levels (≥600 µmol/L for Palynziq eligibility)
  • Treatment history including dietary management attempts
  • Specialist involvement (genetics/metabolism clinic notes)
  • Symptoms or complications related to elevated phenylalanine
Note: Use the most specific code available. E70.0 is preferred for classical PKU cases, while E70.1 covers atypical presentations or mild hyperphenylalaninemia.

Product Coding: HCPCS, NDC, and Units

Understanding Palynziq's complex coding structure prevents billing errors that commonly trigger denials.

HCPCS and NDC Codes

Strength NDC Example HCPCS Billing Unit
2.5 mg/0.5 mL 68135-0058-90 J3590 1 syringe
10 mg/0.5 mL 68135-0673-39 J3590 1 syringe
20 mg/0.5 mL 68135-0673-40 J3590 1 syringe

Units Calculation

Palynziq dosing is individualized and titrated:

  • Starting dose: 2.5 mg weekly, gradually increased
  • Maintenance: Typically 20-60 mg daily
  • Billing example: For 40 mg daily dose = 2 × 20 mg syringes OR 4 × 10 mg syringes

Critical: Bill exact number of syringes dispensed. Each syringe represents one billing unit regardless of strength.

Clean Request Anatomy

A successful Palynziq prior authorization includes these essential elements:

Patient Information

  • Full name, DOB, member ID
  • ICD-10 diagnosis: E70.0 or E70.1 with supporting documentation
  • Current phenylalanine levels: Lab results showing ≥600 µmol/L

Clinical Justification

  • Step therapy documentation: Failed sapropterin trial or contraindication
  • Dietary management history: Detailed nutrition records showing inadequate control
  • Specialist consultation: Genetics/metabolism physician involvement
  • Treatment goals: Specific phenylalanine reduction targets

REMS Requirements

Palynziq requires REMS enrollment due to anaphylaxis risk:

  • Prescriber certification: Completed REMS training
  • Patient enrollment: Documented education and epinephrine access
  • Pharmacy verification: REMS-certified dispensing location

Coding Details

  • HCPCS: J3590 with appropriate NDC
  • Quantity: Exact syringe count per prescribed dose
  • Administration: Include site of care and monitoring plan

Frequent Pitfalls

Avoid these common errors that trigger Palynziq denials:

Unit Conversion Mistakes

  • Error: Billing by milligrams instead of syringes
  • Fix: Always bill per syringe unit (one 20 mg syringe = 1 unit, not 20 units)

Mismatched Codes

  • Error: Using wrong NDC for prescribed strength
  • Fix: Verify NDC matches exact product dispensed

Missing REMS Documentation

  • Error: Submitting PA without REMS enrollment proof
  • Fix: Include prescriber and patient REMS certificates with initial request

Incomplete Step Therapy

  • Error: No documentation of sapropterin trial
  • Fix: Provide detailed records of prior therapy attempts, failures, or contraindications

Wrong Benefit Category

  • Error: Submitting medical claim when plan requires pharmacy benefit
  • Fix: Verify coverage pathway before submission

Verification Steps

Before submitting your Palynziq request, verify these details with Virginia BCBS:

Check Coverage Pathway

  1. Call member services: Number on insurance card
  2. Confirm benefit type: Medical vs. pharmacy coverage
  3. Verify PA requirements: Current forms and criteria
  4. Check formulary status: Tier placement and restrictions

Validate Coding

  • Cross-reference NDC: Confirm with FDA Orange Book
  • Verify HCPCS: J3590 is current unclassified biologic code
  • Check units: Match billing units to product dispensed

Confirm Provider Network

  • Prescriber: In-network genetics/metabolism specialist
  • Pharmacy: REMS-certified specialty pharmacy
  • Administration site: If required for initial doses

Pre-Submission Audit Checklist

Use this checklist before submitting your Palynziq prior authorization:

Patient Documentation

  • Complete member information and ID verification
  • Current insurance card copy
  • ICD-10 code (E70.0 or E70.1) with supporting diagnosis

Clinical Requirements

  • Recent phenylalanine levels ≥600 µmol/L
  • Documented dietary management attempts
  • Step therapy records (sapropterin trial/contraindication)
  • Specialist consultation notes

REMS Compliance

  • Prescriber REMS certification
  • Patient REMS enrollment
  • Epinephrine auto-injector prescription
  • REMS-certified pharmacy identified

Coding Accuracy

  • Correct HCPCS (J3590) and NDC pairing
  • Accurate unit calculation (syringes, not milligrams)
  • Appropriate modifier codes if required

Administrative Details

  • Complete PA form for your specific plan
  • All required signatures and dates
  • Supporting documentation attached
  • Submission method confirmed (portal/fax)

Appeals Process in Virginia

If Virginia BCBS denies your Palynziq request, you have multiple appeal options with specific timelines.

Internal Appeals

Timeline: Must file within plan's specified timeframe (typically 60-180 days) Process: Submit through Anthem provider portal or member services Documentation: Address each denial reason with additional clinical evidence

External Review

Virginia provides independent external review through the State Corporation Commission Bureau of Insurance:

Eligibility: Must exhaust internal appeals first Timeline: 120 days from final denial to request external review Forms: Form 216-A (External Review Request) Submission:

  • Fax: (804) 371-9915
  • Email: [email protected]
  • Mail: SCC Bureau of Insurance, P.O. Box 1157, Richmond, VA 23218

Expedited Appeals

For urgent cases where delay could jeopardize health: Timeline: 72 hours for medical necessity denials Requirements: Physician certification of urgent need Form: Form 216-C (physician certification)

From our advocates: We've seen Virginia patients successfully overturn Palynziq denials by addressing REMS compliance gaps and providing detailed step therapy documentation. The key is methodically addressing each denial reason with specific clinical evidence rather than submitting generic appeals.

Common Denial Reasons & Solutions

Denial Reason Solution Documentation Needed
Insufficient step therapy Document sapropterin trial failure Detailed treatment history, lab results, tolerance issues
Missing REMS enrollment Complete REMS certification Prescriber and patient REMS certificates
Inadequate dietary management Provide comprehensive nutrition records Dietitian notes, food logs, phenylalanine monitoring
Wrong age criteria Confirm patient is 18+ Birth certificate or ID verification
Phenylalanine levels too low Submit current lab results Recent labs showing ≥600 µmol/L
Non-network prescriber Use in-network specialist Genetics/metabolism physician referral
Coding errors Correct HCPCS/NDC mismatch Verify J3590 with appropriate NDC

Cost Assistance and Support

Palynziq's annual cost ranges from $130,000-$443,000, making financial assistance crucial for most patients.

Manufacturer Support

BioMarin RareConnections offers:

  • Prior authorization assistance
  • Appeals support
  • Financial assistance programs
  • REMS enrollment guidance

Additional Resources

  • Patient assistance programs: Income-based eligibility
  • State pharmaceutical assistance: Virginia may offer programs for rare diseases
  • Foundation grants: Various organizations support PKU patients

At Counterforce Health, we help patients navigate complex prior authorization processes by turning insurance denials into targeted, evidence-backed appeals. Our platform analyzes denial letters and payer policies to create compelling rebuttal letters that address specific coverage criteria.

FAQ

How long does Blue Cross Blue Shield Virginia PA take for Palynziq? Standard prior authorization decisions are typically made within 15 business days. Expedited requests for urgent cases may be decided within 72 hours.

What if Palynziq is non-formulary on my plan? You can request a formulary exception by demonstrating medical necessity and lack of appropriate alternatives. Include detailed clinical justification and specialist support.

Can I request an expedited appeal in Virginia? Yes, if your physician certifies that delay could seriously jeopardize your health. Use Form 216-C for physician certification and submit through the SCC Bureau of Insurance.

Does step therapy apply if I failed sapropterin outside Virginia? Yes, documented step therapy failures from other states are generally accepted. Ensure you have complete medical records from your previous provider.

What happens if both internal and external appeals fail? You may file a complaint with the Virginia Bureau of Insurance or consult with a healthcare attorney. Some cases may qualify for additional review processes.

How do I find a REMS-certified prescriber in Virginia? Contact the PALYNZIQ REMS program directly for a list of certified prescribers in your area. Most genetics and metabolism specialists can become certified.

Can I switch from medical to pharmacy benefit coverage? Coverage pathway depends on your specific plan design. Contact Anthem member services to understand your options and any required processes for benefit changes.

Sources & Further Reading

For additional support with complex prior authorization appeals, Counterforce Health specializes in turning insurance denials into successful approvals through evidence-based appeal strategies tailored to specific payer requirements.

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. Policies and procedures may change; verify current requirements with official sources before taking action.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.